GENETIC BIOPSY TESTING

SOL #: 36C24526Q0278Special NoticeSole Source

Overview

Buyer

Veterans Affairs
Veterans Affairs, Department Of

Place of Performance

Baltimore, MD

NAICS

Medical Laboratories (621511)

PSC

Reference Laboratory Testing (Q301)

Set Aside

No set aside specified

Timeline

1
Posted
Feb 9, 2026
2
Action Date
Feb 24, 2026, 8:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Veterans Affairs (VA), Network Contracting Office (NCO) 05, has issued a Notice of Intent (NOI) to award a sole source contract to Veracyte, Inc. for Genetic Biopsy Testing services at the Baltimore VA Medical Center. This action is justified under FAR 6.302-1, citing "Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements."

Scope of Work

Veracyte, Inc. will provide specialized Genetic Biopsy Testing services to support the Baltimore VA Medical Center. The services fall under NAICS code 621511 (Medical Laboratories), with an SBA Size Standard of $41.5 million.

Contract Details

  • Contract Type: Anticipated Fixed Price Indefinite Delivery Indefinite Quantity (IDIQ).
  • Intended Awardee: Veracyte, Inc., located at 6000 Shoreline Court, Suite 300, South San Francisco, CA 94080.
  • Place of Performance: Baltimore, MD 21201.
  • Product Service Code: Q301 (Reference Laboratory Testing).

Set-Aside

This is a sole source action; therefore, no set-aside is applicable.

Important Information & Response

This notice is for informational purposes only and does not constitute a formal solicitation or a request for competitive quotations. No solicitation document is available, and unsolicited offers will not be considered for award. The Government will not be responsible for any costs incurred by interested parties responding to this notice.

However, if other sources believe they can meet the agency's requirements, they may submit a capability statement or other information to challenge the sole source justification.

  • Notice Published: February 9, 2026
  • Response Date (for challenging sole source): February 24, 2026, 8:00 PM EST.
  • Primary Contact: Aria Melville (Aria.Melville@va.gov).

People

Points of Contact

Aria MelvillePRIMARY

Files

Files

Download

Versions

Version 1Viewing
Special Notice
Posted: Feb 9, 2026
GENETIC BIOPSY TESTING | GovScope